Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort

PURPOSE: To examine the long-term persistence to the first-line injectable disease-modifying therapies (DMTs) for multiple sclerosis (MS) and to identify the factors associated with nonpersistence. PATIENTS AND METHODS: We used population-based administrative data from Manitoba, Canada. All adult su...

Descripción completa

Detalles Bibliográficos
Autores principales: Melesse, Dessalegn Y, Marrie, Ruth Ann, Blanchard, James F, Yu, Bo Nancy, Evans, Charity
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499788/
https://www.ncbi.nlm.nih.gov/pubmed/28721023
http://dx.doi.org/10.2147/PPA.S138263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499788/
https://www.ncbi.nlm.nih.gov/pubmed/28721023
http://dx.doi.org/10.2147/PPA.S138263

Ejemplares similares